What Is The RICE Cancer Treatment?

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE", "R-ICE", and "RICE."

Which Drugs Are Used In The Treatment?

RICE combination chemotherapy uses the following drugs

Rituximab is a monoclonal antibody that targets the CD20 protein on the surface of B-lymphocytes, while ifosfamide, carboplatin, and etoposide are all chemotherapeutic drugs that work at various stages of the cell cycle.

The RICE Regimen

The RICE regimen is tailored to each individual patient, but is generally administered according to a 14 day cycle that is repeated three times:

  • Two days before the start of the first cycle, the patient receives an infusion of rituximab.
  • Day 1: More rituximab
  • Day 3: Etoposide
  • Day 4: More etoposide, plus carboplatin and a 24-hour infusion of ifosfamide (mixed with a drug to prevent irritation of the bladder)
  • Day 5: Even more etoposide
  • Days 7-14: Injections of G-CSF, a protein that stimulates the bone marrow to create white blood cells
  • Day 15 = Day 1 of the second cycle

Virtually all patients agree that RICE chemotherapy is an especially brutal chemotherapeutic regimen, with an immense amount of difficult side effects.

What is RICE Used For?

Most often, the RICE chemotherapeutic regimen is used as a preparative regimen in patients with non-Hodgkin's lymphomas of B-cell origin who are about to undergo a hematopoietic stem cell transplantation.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap